Irfan Khan

Irfan Khan

Auto-generated profile, based on publicly available information

Irfan Khan

Department of Chemistry, University at Albany, State University of New York, Albany, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2016 in ACS Central Science
Verified
Journal Article
Open access
JOJose M. Mejia Oneto
Jose M. Mejia Oneto
IKIrfan Khan
Irfan Khan
LSLeah Seebald
Leah Seebald
MRMaksim Royzen
Maksim Royzen
The ability to activate drugs only at desired locations avoiding systemic immunosuppression and other dose limiting toxicities is highly desirable. Here we present a new approach, named local drug activation, that uses bioorthogonal chemistry to concentrate and activate systemic small molecules at a location of choice. This method is independent of endogenous cellular or environmental markers and only depends on the presence of a preimplanted biomaterial near a desired site (e.g., tumor). We demonstrate the clear therapeutic benefit with minimal side effects of this approach in mice over systemic therapy using a doxorubicin pro-drug against xenograft tumors of a type of soft tissue sarcoma (HT1080).

12 December 2018 in ACS Central Science
Verified
Journal Article
Open access
MCMagdalena Czuban
Magdalena Czuban
SSSangeetha Srinivasan
Sangeetha Srinivasan
NYNathan A. Yee
Nathan A. Yee
EAEdgar Agustin
Edgar Agustin
AKAnna Koliszak
Anna Koliszak
JOJose M. Mejia Oneto
Jose M. Mejia Oneto
Systemic administration of antibiotics can cause severe side-effects such as liver and kidney toxicity, destruction of healthy gut bacteria, as well as multidrug resistance. Here, we present a bio-orthogonal chemistry-based strategy toward local prodrug concentration and activation. The strategy is based on the inverse electron-demand Diels–Alder chemistry between trans-cyclooctene and tetrazine and involves a biomaterial that can concentrate and activate multiple doses of systemic antibiotic therapy prodrugs at a local site. We demonstrate that a biomaterial, consisting of alginate hydrogel modified with tetrazine, is efficient at activating multiple doses of prodrugs of vancomycin and daptomycin in vitro as well as in vivo. These results support a drug delivery process that is independent of endogenous environmental markers. This approach is expected to improve therapeutic efficacy with decreased side-effects of antibiotics against bacterial infections. The platform has a wide scope of possible applications such as wound healing, and cancer and immunotherapy.

1 November 2014 in Journal of Virology
Verified
Journal Article
Open access
PDF file
IKIrfan Khan
Irfan Khan
DKDivya S. Katikaneni
Divya S. Katikaneni
QHQingxia Han
Qingxia Han
LSLorena Sanchez-Felipe
Lorena Sanchez-Felipe
KHKentaro Hanada
Kentaro Hanada
KKKouacou Konan
Kouacou Konan
Hepatitis C virus (HCV) assembles its replication complex on cytosolic membrane vesicles often clustered in a membranous web (MW). During infection, HCV NS5A protein activates PI4KIIIα enzyme, causing massive production and redistribution of phosphatidylinositol 4-phosphate (PI4P) lipid to the replication complex. However, the role of PI4P in the HCV life cycle is not well understood. We postulated that PI4P recruits host effectors to modulate HCV genome replication or virus particle production. To test this hypothesis, we generated cell lines for doxycycline-inducible expression of short hairpin RNAs (shRNAs) targeting the PI4P effector, four-phosphate adaptor protein 2 (FAPP2). FAPP2 depletion attenuated HCV infectivity and impeded HCV RNA synthesis. Indeed, FAPP2 has two functional lipid-binding domains specific for PI4P and glycosphingolipids. While expression of the PI4P-binding mutant protein was expected to inhibit HCV replication, a marked drop in replication efficiency was observed unexpectedly with the glycosphingolipid-binding mutant protein. These data suggest that both domains are crucial for the role of FAPP2 in HCV genome replication. We also found that HCV significantly increases the level of some glycosphingolipids, whereas adding these lipids to FAPP2-depleted cells partially rescued replication, further arguing for the importance of glycosphingolipids in HCV RNA synthesis. Interestingly, FAPP2 is redistributed to the replication complex (RC) characterized by HCV NS5A, NS4B, or double-stranded RNA (dsRNA) foci. Additionally, FAPP2 depletion disrupts the RC and alters the colocalization of HCV replicase proteins. Altogether, our study implies that HCV coopts FAPP2 for virus genome replication via PI4P binding and glycosphingolipid transport to the HCV RC. IMPORTANCE Like most viruses with a positive-sense RNA genome, HCV replicates its RNA on remodeled host membranes composed of lipids hijacked from various internal membrane compartments. During infection, HCV induces massive production and retargeting of the PI4P lipid to its replication complex. However, the role of PI4P in HCV replication is not well understood. In this study, we have shown that FAPP2, a PI4P effector and glycosphingolipid-binding protein, is recruited to the HCV replication complex and is required for HCV genome replication and replication complex formation. More importantly, this study demonstrates, for the first time, the crucial role of glycosphingolipids in the HCV life cycle and suggests a link between PI4P and glycosphingolipids in HCV genome replication.

25 January 2016 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
MRMuhit Rana
Muhit Rana
MBMustafa Balcioglu
Mustafa Balcioglu
MKMaya Kovach
Maya Kovach
MHMustafa Salih Hizir
Mustafa Salih Hizir
NRNeil M. Robertson
Neil M. Robertson
MYMehmet V. Yigit
Mehmet V. Yigit
Coupling the DNA polymerization capability of HCR with the plasmonic properties of AuNP for reprogrammable, multiplexed and visual detection of three different circulating oncomiRs in seven different combinations.

14 June 2017 in Chemical Science
Verified
Journal Article
Open access
PDF file
IKIrfan Khan
Irfan Khan
LSLeah M. Seebald
Leah M. Seebald
NRNeil M. Robertson
Neil M. Robertson
MYMehmet V. Yigit
Mehmet V. Yigit
MRMaksim Royzen
Maksim Royzen
In vitro exogenous activation of siRNA nanodrug using bio-orthogonal de-click chemistry.

1 April 2016 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
IKIrfan Khan
Irfan Khan
PAPaul F. Agris
Paul F. Agris
MYMehmet V. Yigit
Mehmet V. Yigit
MRMaksim Royzen
Maksim Royzen
A general strategy for image-guided prodrug activation using fluorescently-labeled magnetic iron oxide nanoparticles is described.